Ergomed’s full year results highlight continued progression and robust growth in its services business. We are expecting three of the group’s co-development partnerships are on track to deliver clinical data in 2016 with positive data providing value inflection points. The group continues to be in discussions for potential new co-development deals and we look forward to them being announced during 2016. We continue to favour Ergomed’s integrated business model of services provision and co-develo ....
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Full year results: clinical data expected in 2016
- Published:
12 Apr 2016 -
Author:
Sheena Berry -
Pages:
4
Ergomed’s full year results highlight continued progression and robust growth in its services business. We are expecting three of the group’s co-development partnerships are on track to deliver clinical data in 2016 with positive data providing value inflection points. The group continues to be in discussions for potential new co-development deals and we look forward to them being announced during 2016. We continue to favour Ergomed’s integrated business model of services provision and co-develo ....